Correlation Between Handa Pharmaceuticals and Unimicron Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and Unimicron Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and Unimicron Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Handa Pharmaceuticals and Unimicron Technology Corp, you can compare the effects of market volatilities on Handa Pharmaceuticals and Unimicron Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of Unimicron Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and Unimicron Technology.

Diversification Opportunities for Handa Pharmaceuticals and Unimicron Technology

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Handa and Unimicron is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and Unimicron Technology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unimicron Technology Corp and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with Unimicron Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unimicron Technology Corp has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and Unimicron Technology go up and down completely randomly.

Pair Corralation between Handa Pharmaceuticals and Unimicron Technology

Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to under-perform the Unimicron Technology. In addition to that, Handa Pharmaceuticals is 1.04 times more volatile than Unimicron Technology Corp. It trades about -0.09 of its total potential returns per unit of risk. Unimicron Technology Corp is currently generating about 0.0 per unit of volatility. If you would invest  17,800  in Unimicron Technology Corp on August 28, 2024 and sell it today you would lose (1,900) from holding Unimicron Technology Corp or give up 10.67% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.71%
ValuesDaily Returns

Handa Pharmaceuticals  vs.  Unimicron Technology Corp

 Performance 
       Timeline  
Handa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Unimicron Technology Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Unimicron Technology Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Unimicron Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Handa Pharmaceuticals and Unimicron Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Handa Pharmaceuticals and Unimicron Technology

The main advantage of trading using opposite Handa Pharmaceuticals and Unimicron Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, Unimicron Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unimicron Technology will offset losses from the drop in Unimicron Technology's long position.
The idea behind Handa Pharmaceuticals and Unimicron Technology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data